newsfilter
← Latest News
GlobeNewswire·

XBiotech Announces Receipt of $75 Million from Sale of Antibody

AUSTIN, Texas, June 30, 2021 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ:XBIT) announced today it received $75 million from funds escrowed as part of its December 2019 sale of bermekimab. The True Human™ antibody developed by the company to treat inflammat